The Prediction of Adverse Maternal Outcomes in Preeclampsia

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 10, 2004, Pages 871-879

  von Dadelszen, Peter ^a   Magee, Laura A ^a   Devarakonda, Rajashree M ^a   Hamilton, Trevor ^a   Ainsworth, Laurie M ^b   Yin, Ruihua ^a   Norena, Monica ^b   Walley, Keith R ^a   Gruslin, Andrée ^c   Moutquin, Jean Marie ^d   Lee, Shoo K ^a   Russell, James A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

HELLP syndrome; Multivariate analysis; Pre eclampsia; Risk factors

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; FIBRINOGEN; INOTROPIC AGENT; LACTATE DEHYDROGENASE; URATE; URIC ACID; BIOLOGICAL MARKER;

ADULT; ADVERSE MATERNAL OUTCOME; ADVERSE OUTCOME; AMNIOTIC FLUID INDEX; ARTICLE; BLOOD PRESSURE; BLOOD TRANSFUSION; CEREBRAL BLINDNESS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DIPSTICK PROTEINURIA; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; FEMALE; FETUS WEIGHT; FRACTION OF INSPIRED OXYGEN OXYGEN SATURATION RATIO; GESTATIONAL AGE; GLASGOW COMA SCALE; HEART INFARCTION; HEMATOLOGICAL PARAMETERS; HEMATOMA; HUMAN; INTUBATION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LIVER FAILURE; MAJOR CLINICAL STUDY; MATERNAL DEATH; MEAN PLATELET VOLUME PLATELET COUNT RATIO; MEDICAL RECORD REVIEW; MULTIORGAN DYSFUNCTION; MULTIPLE ORGAN FAILURE; OXYGEN CONSUMPTION; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PREDICTION; PREECLAMPSIA; PROTEINURIA; RENAL REPLACEMENT THERAPY; RESPIRATORY TRACT PARAMETERS; RETROSPECTIVE STUDY; RISK FACTOR; SEIZURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; UMBILICAL ARTERY END DIASTOLIC FLOW; URINE VOLUME; BLOOD; HOSPITALIZATION; INFANT MORTALITY; MATERNAL MORTALITY; MORTALITY; NEWBORN; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; STATISTICAL MODEL; URINE;

ADULT; BIOLOGICAL MARKERS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; LOGISTIC MODELS; MATERNAL MORTALITY; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 16644382737     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30137-2     Document Type: Article

References (44)

1. Why women die. Report on confidential enquiries into maternal deaths in the United Kingdom 1994-1996 1999, Department of Health, HMSO, London.
2. Why women die. Report on confidential enquiries into maternal deaths in the United Kingom, 1997-1999 2001, National Institute for Clinical Excellence, RCOG Press, London.
3. Pregnancy-related mortality surveillance: United States, 1987-1990. MMWR Morb Mortal Wkly Rep 1997;46(SS-4): 17-36.
4. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993, 341:1447-1451.
5. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999, 318:1332-1336.
6. Magee LA, Cham C., Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: metaanalysis. BMJ 2003, 327:955-960.
7. von Dadelszen P, Magee LA, Marshall JC Rotstein OD.The maternal syndrome of preeclampsia: a forme fruste of the systemic inflammatory response syndrome. Sepsis 2000, 4:43-47.
8. von Dadelszen P, Magee LA, Lee SK, Stewart SD, Simone C, Koren G, et al. Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity?. Crit Care Med 2002, 30:1883-1892.
9. Stevenson DK, Wright LL, Lemons JA, Oh W, Korones SB, Papile LA Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network,January 1993 through December 1994. Am J Obstet Gynecol 1998, 179:1632-1639.
10. Odendaal HJ, Pattinson RC, Bam R, Grove D KotzeTJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990, 76:1070-1075.
11. Olah KS, Redman CW, Gee H. Management of severe, early pre-eclampsia: is conservative management justified?. Eur J Obstet Gynecol Reprod Biol 1993, 51:175-180.
12. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997, 157:715-725.
13. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;I83:SI-S22.
14. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N ZJ Obstet Gynaecol 2000, 40:139-155.
15. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregn 2001, 20:ix-xiv.
16. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994, 309:1395-1400.
17. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998, 338:701-705.
18. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002, 186:66-71.
19. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregn 2003, 22:143-148.
20. MacKay AP, Berg CJ, Atrash HK Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001, 97:533-538.
21. Opsjon SL, Austgulen R, Waage A. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstet Gynecol Scand 1995, 74:19-26.
22. von Dadelszen P, Magee LA, Krajden M, Alasaly K, Popovska V, Devarakonda RM Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. Br J Obstet Gynaecol 2003, 110:725-730.
23. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994, 171:818-822.
24. Redman CWG. Platelets and the beginnings of preeclampsia. N Engl J Med 1990, 323:478-480.
25. Redman CW, Bonnar J, Beilin L Early platelet consumption in preeclampsia. BMJ 1978, 1:467-469.
26. Rosevear SK, Liggins GC. Platelet dimensions in pregnancy-induced hypertension. N Z Med J 1986, 99:356-357.
27. Walker JJ, Cameron AD, Bjornsson S, Singer CR, Fräser C. Can platelet volume predict progressive hypertensive disease in pregnancy?. Am J Obstet Gynecol 1989, 161:676-679.
28. Knaus W.Wagner D, Draper E. APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Implications. Crit Care Med 1989, 17:S219-S221.
29. Knaus W, Wagner D, Draper E APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Development of APACHE. Crit Care Med 1989, 17:S181-S185.
30. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652.
31. Redman CWG, Sacks GP Sargent IL Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 180:499-506.
32. Milholland AV, Wheeler SG, Heieck JJ Medical assessment by a Delphi group opinion technic. N Engl J Med 1973, 288:1272-1275.
33. Pill J The Delphi method: substance, context, a critique and an annotated bibliography. Socio-Economic Planning Science 1971, 5:57-71.
34. Richardson D, Tarnow-Mordi WO, Lee SK Risk adjustment for quality improvement Pediatrics 1999, 103:255-265.
35. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996, 175:460-464.
36. Hosmer D, Lemeshow S Applied logistic regression 1989, 135-175. John Wiley and Sons, New York. D. Hosmer, S. Lemeshow (Eds.).
37. Weinstein L Syndrome of hemolysis, elevated liver enzymes, and low platelet count a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142:159-167.
38. Knaus W, Wagner D APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Individual patient decisions. Crit Care Med 1989, 17:S204-S209.
39. Jacobs S, Zuleika M, Mphansa T The Multiple Organ Dysfunction Score as a descriptor of patient outcome in septic shock compared with two other scoring systems. Crit Care Med 1999, 27:741-744.
40. Belfort MA. Scoring systems for eclampsia. Crit Care Med 2000, 28:272-273.
41. Bhagwanjee S, Paruk F, Moodley J, Muckart DJ. Intensive care unit morbidity and mortality from eclampsia: an evaluation of the Acute Physiology and Chronic Health Evaluation II score and the Glasgow Coma Scale score. Crit Care Med 2000, 28:120-124.
42. Richardson DK, Gray JE McCormick MC.Workman K, Goldmann DA. Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics 1993, 91:617-623.
43. Piguel D, Pierre F, Pourrat O, D'Halluin G, Magnin G. Are the symptoms relevant enough to predict the occurrence of pre-eclampsia?. Hypertens Pregn 2002, 21:51.
44. Stoger S, Walters BN Diagnostic value of the clinical history in preeclampsia. Hypertens Pregn 2002, 21:48.